AMD CTO Mark Papermaster recently sat down with Absci Founder and CEO Sean McClain to discuss our new collaboration, and how AMD technology can help provide faster, more efficient, and optimized generative AI solutions in drug discovery and biotechnology.
In case you missed Absci Founder & CEO Sean McClain's talk at JPM yesterday, you can check out his fireside chat with AMD's CTO Mark Papermaster here: https://lnkd.in/gA5x3PY2 Our collaboration with AMD and exciting advancements on our platform and pipeline programs can be viewed here: https://lnkd.in/emtqW7tf #AI #Biologics #DrugDiscovery